Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pengxun Han

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
American Journal of Translational Research|May 9, 2018
Niclosamide ethanolamine improves diabetes and diabetic kidney disease in micePengxun Han, Mumin Shao, Lan Guo, et al.
American Journal of Translational Research|April 12, 2019
Artemether ameliorates type 2 diabetic kidney disease by increasing mitochondrial pyruvate carrier content in db/db micePengxun Han, Yao Wang, Hongyue Zhan, et al.
Biomed Research International|May 23, 2022
Artemether Alleviates Diabetic Kidney Disease by Modulating Amino Acid MetabolismGuangli Rong, Wenci Weng, Jingting Huang, et al.
American Journal of Translational Research|March 23, 2019
Niclosamide ethanolamine protects kidney in adriamycin nephropathy by regulating mitochondrial redox balancePengxun Han, Changjian Yuan, Yao Wang, et al.
American Journal of Translational Research|April 15, 2022
Artemether attenuates renal tubular injury by targeting mitochondria in adriamycin nephropathy miceXinyuan Cheng, Peng Zhou, Wenci Weng, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
American Journal of Translational Research|May 9, 2018
Niclosamide ethanolamine improves diabetes and diabetic kidney disease in micePengxun Han, Mumin Shao, Lan Guo, et al.
American Journal of Translational Research|April 12, 2019
Artemether ameliorates type 2 diabetic kidney disease by increasing mitochondrial pyruvate carrier content in db/db micePengxun Han, Yao Wang, Hongyue Zhan, et al.
Biomed Research International|May 23, 2022
Artemether Alleviates Diabetic Kidney Disease by Modulating Amino Acid MetabolismGuangli Rong, Wenci Weng, Jingting Huang, et al.
American Journal of Translational Research|March 23, 2019
Niclosamide ethanolamine protects kidney in adriamycin nephropathy by regulating mitochondrial redox balancePengxun Han, Changjian Yuan, Yao Wang, et al.
American Journal of Translational Research|April 15, 2022
Artemether attenuates renal tubular injury by targeting mitochondria in adriamycin nephropathy miceXinyuan Cheng, Peng Zhou, Wenci Weng, et al.
Pageof 3